Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Discovery and characterization of novel CID peptidomimetic, DB-550

Jan. 4, 2019

Transcription factor suppresses immunity, halts lupus in mice

Dec. 31, 2018

Momenta initiates phase II trial of M-281 in generalized myasthenia gravis

Dec. 27, 2018

FDA approves IND for anti-GM-CSF monoclonal antibody TJM2

Dec. 24, 2018

Phase II study of zilucoplan in gMG meets primary and key secondary endpoints

Dec. 11, 2018

Positive preliminary phase I data presented for TransCon CNP

Nov. 30, 2018

Takeda describes new BRD4 BD2 domain inhibitors

Nov. 30, 2018

Phase III results of the IL-17A antagonist ixekizumab for radiographic axial spondyloarthritis

Nov. 8, 2018

FDA approves adalimumab biosimilar Hyrimoz

Nov. 5, 2018

ASP-5094 safe and well tolerated in patients with rheumatoid arthritis on methotrexate

Oct. 29, 2018

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...